CompletedPHASE1, PHASE2NCT02179853

Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease

Studying Kawasaki disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Diego
Principal Investigator
Adriana H Tremoulet, MD
UCSD
Intervention
Anakinra(drug)
Enrollment
22 enrolled
Eligibility
17 years · All sexes
Timeline
2014 – 2022

Study locations (1)

Collaborators

Boston Children's Hospital · Cedars-Sinai Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02179853 on ClinicalTrials.gov

Other trials for Kawasaki disease

Additional recruiting or active studies for the same condition.

See all trials for Kawasaki disease →

← Back to all trials